Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products
August 19, 2021
Ryan Allway August 19th, 2021 Psychedelics TORONTO and CAPE TOWN, South Africa, Aug. 18, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“ Psyence ” or the “ Company ”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce the commencement of online... Read more
Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing
July 29, 2021
Ryan Allway July 29th, 2021 Psychedelics Health Canada Dealer’s License to allow the possession, production, and delivery of all controlled natural psychedelic substances VANCOUVER, BC , July 29, 2021 /CNW/ – Filament Health Corp. (NEO: FH) (“Filament” or the “Company”), a global leader in natural psychedelic drug development, has been granted an amendment to its... Read more
Ryan Allway May 21st, 2021 Psychedelics VANCOUVER, BC, May 17, 2021 /CNW/ – Filament Ventures Corp. (“Filament” or the “Company”), an exclusively-natural psychedelic drug discovery and extraction company, is pleased to announce that it has entered into an agreement with Echelon Wealth Partners Inc. and Canaccord Genuity Corp. (together,... Read more
